The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer
Abstract Background Prostate cancer (PC) is the most commonly diagnosed male malignancy and an important cause of mortality. Androgen deprivation therapy is the first line treatment but, unfortunately, a large part of patients evolves to a castration-resistant stage, for which no effective cure is c...
Main Authors: | Lidia Chellini, Marco Pieraccioli, Claudio Sette, Maria Paola Paronetto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | https://doi.org/10.1186/s13046-022-02384-4 |
Similar Items
-
P733: DHX9 HELICASE DYSFUNCTION CONTRIBUTES TO DISEASE PROGRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
by: N.-F. Huang, et al.
Published: (2022-06-01) -
The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma
by: Le-gao Chen, et al.
Published: (2022-12-01) -
Poison-Exon Inclusion in DHX9 Reduces Its Expression and Sensitizes Ewing Sarcoma Cells to Chemotherapeutic Treatment
by: Ramona Palombo, et al.
Published: (2020-01-01) -
Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9
by: Juliana S Capitanio, et al.
Published: (2017-02-01) -
High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma
by: Xi Chen, et al.
Published: (2022-06-01)